Teleflex Incorporated (TFX)
NYSE: TFX · Real-Time Price · USD
120.50
+1.64 (1.38%)
Dec 5, 2025, 4:00 PM EST - Market closed
Teleflex Market Cap
Teleflex has a market cap or net worth of $5.33 billion as of December 5, 2025. Its market cap has decreased by -40.61% in one year.
Market Cap
5.33B
Enterprise Value
7.84B
1-Year Change
-40.61%
Ranking
Category
Stock Price
$120.50
Market Cap Chart
Since December 1, 1998, Teleflex's market cap has increased from $1.57B to $5.33B, an increase of 239.39%. That is a compound annual growth rate of 4.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 5.33B | -35.58% |
| Dec 31, 2024 | 8.27B | -29.45% |
| Dec 29, 2023 | 11.72B | 0.07% |
| Dec 30, 2022 | 11.71B | -23.90% |
| Dec 31, 2021 | 15.39B | -19.71% |
| Dec 31, 2020 | 19.17B | 9.97% |
| Dec 31, 2019 | 17.43B | 46.63% |
| Dec 31, 2018 | 11.89B | 6.03% |
| Dec 29, 2017 | 11.21B | 57.89% |
| Dec 30, 2016 | 7.10B | 29.82% |
| Dec 31, 2015 | 5.47B | 15.00% |
| Dec 31, 2014 | 4.76B | 23.13% |
| Dec 31, 2013 | 3.86B | 32.31% |
| Dec 31, 2012 | 2.92B | 16.96% |
| Dec 30, 2011 | 2.50B | 15.99% |
| Dec 31, 2010 | 2.15B | 0.50% |
| Dec 31, 2009 | 2.14B | 7.60% |
| Dec 31, 2008 | 1.99B | -20.05% |
| Dec 31, 2007 | 2.49B | -1.20% |
| Dec 29, 2006 | 2.52B | -4.28% |
| Dec 30, 2005 | 2.63B | 25.73% |
| Dec 31, 2004 | 2.09B | 9.10% |
| Dec 31, 2003 | 1.92B | 13.63% |
| Dec 31, 2002 | 1.69B | -8.19% |
| Dec 31, 2001 | 1.84B | 8.77% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 908.36B |
| Johnson & Johnson | 487.83B |
| AbbVie | 404.22B |
| UnitedHealth Group | 302.09B |
| AstraZeneca | 279.81B |
| Novartis AG | 255.73B |
| Merck & Co. | 250.41B |
| Abbott Laboratories | 218.05B |